Message from our Honorary President, Colin Osborne

Professor Tim Oliver MD FRCP (1942–2026)

Rest in Peace

It is with profound sadness that I mark the death of Professor Tim Oliver. Tim passed away peacefully on Saturday, surrounded by his family. Tim was an exceptional oncologist, a pioneering medical researcher and the man to whom I owe my life.

I first knew Tim as my consultant, when I was undergoing treatment for advanced testicular cancer. My prospects were extremely poor, but Tim refused to give up on me. Through his extraordinary clinical knowledge, his willingness to explore new approaches and his quiet determination, he gave me something beyond treatment: he gave me hope. Because of his skill and judgement, I survived to see my children grow up, something I will always regard as his greatest gift to me and my family.

Tim was such a special friend. Our relationship developed from that of doctor and patient into an enduring partnership with a shared purpose. In 1996, Tim and I founded Orchid. We wanted to create a charity that would fund innovative research, improve awareness and ensure that men and their families received better information and support following a diagnosis of testicular, prostate or penile cancer.

Tim’s vision shaped Orchid from its earliest days. He believed passionately that meaningful progress depended upon looking beyond established conventions, asking difficult questions and following promising scientific connections wherever they might lead. His intellectual curiosity was boundless, but it was always grounded in a desire to improve the lives and prospects of patients.

Tim studied at St John’s College, Cambridge, and the Royal London Hospital. Following his training in cancer medicine at St Bartholomew’s Hospital, he moved to the Institute of Urology, where he pioneered drug treatments for male cancers. On returning to St Bartholomew’s and the Royal London, he helped create a clinical trials network linking hospitals across East Anglia and Essex. This collaboration enabled new treatments to be studied on a scale that individual centres could not have achieved alone.

As Consultant Oncologist and Professor of Medical Oncology at St Bartholomew’s and the Royal London Hospital School of Medicine and Dentistry, Tim became an internationally respected authority on male cancers. He contributed to major international research initiatives in testicular and prostate cancer through the European Organisation for Research and Treatment of Cancer and played an important part in developing treatments that transformed outcomes for countless men.

His influence extended far beyond his own patients. The research programme he inspired at Orchid helped challenge conventional thinking about male cancers and contributed to new avenues of scientific investigation. His vision also led to the establishment in 2006 of a Clinical Trials Unit within the Experimental Cancer Medicine Centre at Barts and the London School of Medicine at Queen Mary University of London.

Tim’s achievements can be measured in research papers, clinical trials and advances in treatment, but those measures tell only part of the story. His true legacy lives in the men who survived cancer, enjoyed more years with their families and especially

those who were able to survive and go on to father children thanks to Tim’s focus on reducing the toxicity of cancer treatment.

He served Orchid for 30 years as a trustee and later as an Honorary President, providing wisdom, scientific leadership and an unwavering commitment to the charity’s mission. Even after stepping down as a trustee, he continued to advise Orchid on its research initiatives. His influence is woven into the fabric of the organisation and will remain there for generations to come.

For me, Tim was much more than an eminent professor or a distinguished oncologist. He was the doctor who stood beside me at the most frightening time of my life, the man who saved me when the odds were overwhelmingly against me, and the person with whom I was privileged to create a charity that has helped so many others.

Professor Tim Oliver devoted his life to advancing knowledge, challenging accepted thinking and giving people affected by cancer a better chance of survival. His contribution to medicine and to Orchid was immense. His loss will be felt deeply by his former patients, colleagues and everyone whose life was touched by his dedication.

I will always be grateful for his courage, his brilliance and his humanity. Orchid itself stands as a lasting tribute to everything Tim believed in and worked for.

He will be greatly missed and remembered with profound affection, admiration and gratitude.

In closing I am so lucky to have had Tim treat me, I am sure that without Tim I would not be here today. He became such a special friend to me and my family. In closing I’m sure Tim would agree that I was lucky Tim was better as an oncologist than he was at golf. RIP Tim, my dear friend.

Colin Osborne MBE Co-founder of Orchid – Fighting Male Cancer

Back to News